Literature DB >> 16545840

Natural and experimental infection of sheep with European bat lyssavirus type-1 of Danish bat origin.

K Tjørnehøj1, A R Fooks, J S Agerholm, L Rønsholt.   

Abstract

In 1998 and 2002, European bat lyssavirus type-1 (EBLV-1) was demonstrated in brain tissue of five Danish sheep suffering from neurological disorders. Four of the five sheep also had encephalic listeriosis. The animals originated from four flocks on pastures within a limited area of western Jutland. In a serological investigation in two of the herds, from which three of the diseased animals originated, EBLV-1 neutralizing antibodies were detected in only one of 69 sheep. In follow-up surveys, 2110 sheep sera collected at Danish slaughterhouses during 2000 were all negative for EBLV-1-antibodies, and EBLV-1 was not demonstrated in 87 ruminants displaying neurological symptoms. To investigate the pathogenic effects of EBLV-1, four sheep were inoculated intralabially with either brain material from one of the naturally infected sheep or virus isolated from the same sheep. These animals developed EBLV-1 neutralizing antibodies at 5-9 weeks post-inoculation but did not exhibit neurological signs during a 33-week observation period. It was speculated that the immune response prevented viral dissemination to the brain, resulting in an abortive peripheral infection. It was concluded that EBLV-1 can infect sheep under natural conditions as an incidental event.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16545840     DOI: 10.1016/j.jcpa.2005.10.005

Source DB:  PubMed          Journal:  J Comp Pathol        ISSN: 0021-9975            Impact factor:   1.311


  23 in total

1.  Metagenomic analysis of viruses from bat fecal samples reveals many novel viruses in insectivorous bats in China.

Authors:  Xingyi Ge; Yan Li; Xinglou Yang; Huajun Zhang; Peng Zhou; Yunzhi Zhang; Zhengli Shi
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

2.  Intergenotypic replacement of lyssavirus matrix proteins demonstrates the role of lyssavirus M proteins in intracellular virus accumulation.

Authors:  Stefan Finke; Harald Granzow; Jose Hurst; Reiko Pollin; Thomas C Mettenleiter
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

3.  Computational analysis suggests that lyssavirus glycoprotein gene plays a minor role in viral adaptation.

Authors:  Kevin Tang; Xianfu Wu
Journal:  Int J Evol Biol       Date:  2011-02-06

4.  Cross sectional survey of human-bat interaction in Australia: public health implications.

Authors:  Beverley J Paterson; Michelle T Butler; Keith Eastwood; Patrick M Cashman; Alison Jones; David N Durrheim
Journal:  BMC Public Health       Date:  2014-01-21       Impact factor: 3.295

5.  Bat rabies surveillance in Finland.

Authors:  Tiina Nokireki; Anita Huovilainen; Thomas Lilley; Eeva-Maria Kyheröinen; Christine Ek-Kommonen; Liisa Sihvonen; Miia Jakava-Viljanen
Journal:  BMC Vet Res       Date:  2013-09-08       Impact factor: 2.741

Review 6.  European bats as carriers of viruses with zoonotic potential.

Authors:  Claudia Kohl; Andreas Kurth
Journal:  Viruses       Date:  2014-08-13       Impact factor: 5.048

7.  Bat and virus.

Authors:  Zhengli Shi
Journal:  Protein Cell       Date:  2010-02       Impact factor: 14.870

8.  Lyssavirus-reactive antibodies in Swedish bats.

Authors:  Anna-Lena Hammarin; Louise Treiberg Berndtsson; Kerstin Falk; Marie Nedinge; Gert Olsson; Åke Lundkvist
Journal:  Infect Ecol Epidemiol       Date:  2016-12-13

9.  European bat Lyssavirus transmission among cats, Europe.

Authors:  Laurent Dacheux; Florence Larrous; Alexandra Mailles; Didier Boisseleau; Olivier Delmas; Charlotte Biron; Christiane Bouchier; Isabelle Capek; Michel Muller; Frédéric Ilari; Tanguy Lefranc; François Raffi; Maryvonne Goudal; Hervé Bourhy
Journal:  Emerg Infect Dis       Date:  2009-02       Impact factor: 6.883

10.  Comparative studies on the genetic, antigenic and pathogenic characteristics of Bokeloh bat lyssavirus.

Authors:  Tobias Nolden; Ashley C Banyard; Stefan Finke; Anthony R Fooks; Dennis Hanke; Dirk Höper; Daniel L Horton; Thomas C Mettenleiter; Thomas Müller; Jens P Teifke; Conrad M Freuling
Journal:  J Gen Virol       Date:  2014-05-14       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.